NASDAQ:IMRA

IMARA News Headlines

$7.42
+0.27 (+3.78 %)
(As of 04/14/2021 04:00 PM ET)
Add
Compare
Today's Range
$7.09
Now: $7.42
$7.58
50-Day Range
$7.29
MA: $9.93
$13.86
52-Week Range
$6.88
Now: $7.42
$62.71
Volume59,583 shs
Average Volume158,103 shs
Market Capitalization$130.41 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

IMARA (NASDAQ IMRA) News Headlines Today

SourceHeadline
The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data - Yahoo FinanceThe Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data - Yahoo Finance
finance.yahoo.com - April 8 at 3:39 PM
IMARA Inc. (NASDAQ:IMRA) Short Interest UpdateIMARA Inc. (NASDAQ:IMRA) Short Interest Update
americanbankingnews.com - April 1 at 12:00 PM
The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO - BenzingaThe Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO - Benzinga
benzinga.com - March 31 at 9:45 AM
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarins Vascepa Snags European Approval, Biocept Jumps On Earnings - BenzingaThe Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings - Benzinga
benzinga.com - March 30 at 8:41 AM
Chicago: AHF Health Center-Lakeview to Open March 31st - StreetInsider.comChicago: AHF Health Center-Lakeview to Open March 31st - StreetInsider.com
streetinsider.com - March 29 at 12:38 PM
Imara Opens Applications for the Second-Annual Real Impact Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders - GlobeNewswireImara Opens Applications for the Second-Annual 'Real Impact' Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders - GlobeNewswire
globenewswire.com - March 29 at 12:38 PM
Imara Opens Applications for the Second-Annual ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood DisordersImara Opens Applications for the Second-Annual ‘Real Impact’ Community Support Program to Address Unmet Needs Affecting People with Rare Genetic Blood Disorders
finance.yahoo.com - March 29 at 7:37 AM
SHAREHOLDER ALERT: Investigation of IMARA Inc. Announced by Holzer & Holzer, LLC - Yahoo FinanceSHAREHOLDER ALERT: Investigation of IMARA Inc. Announced by Holzer & Holzer, LLC - Yahoo Finance
finance.yahoo.com - March 22 at 7:21 PM
SHAREHOLDER ALERT: Investigation of IMARA Inc. Announced by Holzer & Holzer, LLCSHAREHOLDER ALERT: Investigation of IMARA Inc. Announced by Holzer & Holzer, LLC
finance.yahoo.com - March 22 at 7:20 PM
Imara gets positive DMC opinion for higher dose arm in mid-stage sickle cell disease trial - Seeking AlphaImara gets positive DMC opinion for higher dose arm in mid-stage sickle cell disease trial - Seeking Alpha
seekingalpha.com - March 17 at 12:18 PM
Imara Inc. (IMRA) Begins Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia - StreetInsider.comImara Inc. (IMRA) Begins Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia - StreetInsider.com
streetinsider.com - March 17 at 7:17 AM
Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia - GlobeNewswireImara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia - GlobeNewswire
globenewswire.com - March 17 at 7:17 AM
Imara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-ThalassemiaImara Announces Opening of Higher Dose Arms in Global Phase 2b Clinical Trials of IMR-687 for Sickle Cell Disease and Beta-Thalassemia
finance.yahoo.com - March 17 at 7:17 AM
IMARA, Inc. Rings the Nasdaq Stock Market Closing BellIMARA, Inc. Rings the Nasdaq Stock Market Closing Bell
nasdaq.com - March 16 at 10:39 AM
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of IMARA, Inc. (IMRA) and Encourages Investors to Contact the Firm - Yahoo FinanceBronstein, Gewirtz & Grossman, LLC Announces Investigation of IMARA, Inc. (IMRA) and Encourages Investors to Contact the Firm - Yahoo Finance
finance.yahoo.com - March 15 at 11:37 PM
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of IMARA, Inc. (IMRA) and Encourages Investors to Contact the FirmBronstein, Gewirtz & Grossman, LLC Announces Investigation of IMARA, Inc. (IMRA) and Encourages Investors to Contact the Firm
finance.yahoo.com - March 15 at 1:36 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IMARA, Inc. - IMRA - Yahoo FinanceSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IMARA, Inc. - IMRA - Yahoo Finance
finance.yahoo.com - March 15 at 12:07 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IMARA, Inc. - IMRASHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of IMARA, Inc. - IMRA
finance.yahoo.com - March 10 at 7:15 AM
Puerto Rico: New AHF Carolina Healthcare Center and AHF Pharmacy to Open March 9 - Paseo del Prado Shopping Center - StreetInsider.comPuerto Rico: New AHF Carolina Healthcare Center and AHF Pharmacy to Open March 9 - Paseo del Prado Shopping Center - StreetInsider.com
streetinsider.com - March 9 at 10:33 AM
Earnings Scheduled For March 5, 2021 - Yahoo FinanceEarnings Scheduled For March 5, 2021 - Yahoo Finance
finance.yahoo.com - March 5 at 8:42 PM
Form 8-K IMARA Inc. For: Mar 05 - StreetInsider.comForm 8-K IMARA Inc. For: Mar 05 - StreetInsider.com
streetinsider.com - March 5 at 8:42 PM
Imara, Inc. (IMRA) CEO Rahul Ballal on Q4 2020 Results - Earnings Call Transcript - Seeking AlphaImara, Inc. (IMRA) CEO Rahul Ballal on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 5 at 8:42 PM
Second Sight Medical Products, XTL Biopharmaceuticals leads healthcare gainers - Seeking AlphaSecond Sight Medical Products, XTL Biopharmaceuticals leads healthcare gainers - Seeking Alpha
seekingalpha.com - March 5 at 3:08 PM
Mid-Afternoon Market Update: Nasdaq Surges 150 Points; Calyxt Shares Slide - BenzingaMid-Afternoon Market Update: Nasdaq Surges 150 Points; Calyxt Shares Slide - Benzinga
benzinga.com - March 5 at 3:08 PM
Form 10-K IMARA Inc. For: Dec 31 - StreetInsider.comForm 10-K IMARA Inc. For: Dec 31 - StreetInsider.com
streetinsider.com - March 5 at 9:27 AM
Imara Inc to Host Earnings Call - Yahoo FinanceImara Inc to Host Earnings Call - Yahoo Finance
finance.yahoo.com - March 5 at 9:27 AM
Imara Reports Full Year 2020 Financial Results and Business Highlights - GlobeNewswireImara Reports Full Year 2020 Financial Results and Business Highlights - GlobeNewswire
globenewswire.com - March 5 at 9:27 AM
Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights - GlobeNewswireImara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights - GlobeNewswire
globenewswire.com - February 27 at 1:34 AM
Imara to Webcast Conference Call of Full Year 2020 Financial Results and Business HighlightsImara to Webcast Conference Call of Full Year 2020 Financial Results and Business Highlights
finance.yahoo.com - February 27 at 1:34 AM
Alpha Phi Alpha Fraternity, Inc.s Project Alpha and Global AIDS Service Organization Extend Partnership to Address Rising STIs Among Black Youth - StreetInsider.comAlpha Phi Alpha Fraternity, Inc.'s Project Alpha and Global AIDS Service Organization Extend Partnership to Address Rising STIs Among Black Youth - StreetInsider.com
streetinsider.com - February 26 at 8:33 PM
Out of the Closet Thrift Store Opens in Orlando to Address Orlandos HIV/AIDS Epidemic - StreetInsider.com'Out of the Closet' Thrift Store Opens in Orlando to Address Orlando's HIV/AIDS Epidemic - StreetInsider.com
streetinsider.com - February 26 at 8:33 PM
Community Leaders Join Forces with Historic African American Cultural Institution to Culminate Black History Month by Providing Critical Needs to Food Insecure Individuals and Families - StreetInsider.comCommunity Leaders Join Forces with Historic African American Cultural Institution to Culminate Black History Month by Providing Critical Needs to Food Insecure Individuals and Families - StreetInsider.com
streetinsider.com - February 26 at 10:25 AM
Imara to Present at SVB Leerink 10th Annual Global Healthcare ConferenceImara to Present at SVB Leerink 10th Annual Global Healthcare Conference
finance.yahoo.com - February 19 at 7:24 AM
Imara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical OfficerImara Announces the Appointment of Kenneth Attie, M.D. as Chief Medical Officer
finance.yahoo.com - January 20 at 9:18 AM
Imara declined yesterday as its sickle cell treatment appears to be not at par with its peersImara declined yesterday as its sickle cell treatment appears to be not at par with its peers
seekingalpha.com - January 13 at 7:45 AM
Imara Analyst Says Buy The Weakness Ahead Of Multiple 2021 Data ReadoutsImara Analyst Says Buy The Weakness Ahead Of Multiple 2021 Data Readouts
msn.com - January 6 at 7:24 PM
Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell DiseaseImara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with Sickle Cell Disease
finance.yahoo.com - January 6 at 9:11 AM
We Think IMARA (NASDAQ:IMRA) Can Afford To Drive Business GrowthWe Think IMARA (NASDAQ:IMRA) Can Afford To Drive Business Growth
finance.yahoo.com - December 10 at 8:31 AM
Imara Presents IMR-687 Phase 2a Open Label Extension Case Reports on Two Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and ExpositionImara Presents IMR-687 Phase 2a Open Label Extension Case Reports on Two Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and Exposition
finance.yahoo.com - December 7 at 7:49 AM
Do Hedge Funds Love IMARA Inc. (IMRA)?Do Hedge Funds Love IMARA Inc. (IMRA)?
finance.yahoo.com - December 1 at 12:56 AM
Imara to Present Clinical Data on IMR-687 as Monotherapy and in Combination with Hydroxyurea in Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and ExpositionImara to Present Clinical Data on IMR-687 as Monotherapy and in Combination with Hydroxyurea in Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and Exposition
finance.yahoo.com - November 30 at 2:55 PM
Imara Announces the Appointment of Lynette Hopkinson as Senior Vice President of RegulatoryImara Announces the Appointment of Lynette Hopkinson as Senior Vice President of Regulatory
finance.yahoo.com - November 17 at 8:32 AM
IMARA Inc.s (IMRA) CEO Rahul Ballal on Q3 2020 Results - Earnings Call TranscriptIMARA Inc.'s (IMRA) CEO Rahul Ballal on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 7 at 11:27 AM
Imara Reports Third Quarter 2020 Financial Results and Business HighlightsImara Reports Third Quarter 2020 Financial Results and Business Highlights
finance.yahoo.com - November 5 at 9:19 AM
Kaskela Law LLC Announces Stockholder Investigation of Imara Inc. - IMRAKaskela Law LLC Announces Stockholder Investigation of Imara Inc. - IMRA
finance.yahoo.com - October 31 at 8:43 AM
Imara to Webcast Conference Call of Third Quarter Financial ResultsImara to Webcast Conference Call of Third Quarter Financial Results
finance.yahoo.com - October 29 at 7:23 AM
Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in Beta-ThalassemiaImara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in Beta-Thalassemia
finance.yahoo.com - October 16 at 12:54 PM
Imara to Present at Upcoming Investor ConferencesImara to Present at Upcoming Investor Conferences
finance.yahoo.com - September 2 at 9:31 AM
Imara Receives Orphan Drug Designation from the European Commission for IMR-687 for the Treatment of Sickle Cell DiseaseImara Receives Orphan Drug Designation from the European Commission for IMR-687 for the Treatment of Sickle Cell Disease
finance.yahoo.com - August 25 at 9:37 AM
Imara Reports Second Quarter 2020 Financial Results and Business HighlightsImara Reports Second Quarter 2020 Financial Results and Business Highlights
finance.yahoo.com - August 14 at 8:08 AM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.